The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists,PPAR&ggr; Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|4|1|35-52

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.4, Iss.1, 2004-03, pp. : 35-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor  (PPAR) and sepsis

By Knethen Andreas   Soller Mathias   Brüne Bernhard  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 1, 2007-02 ,pp. : 19-25

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 513-525

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; in Vascular Biology

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) in Regenerative Medicine: Molecular Mechanism for PPAR in Stem Cells’ Adipocyte Differentiation

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-04 ,pp. : 290-298

Bentham Science Publishers

Access to resources Recommend Favorite

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-03 ,pp. : 290-298

Bentham Science Publishers

Access to resources Recommend Favorite